Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial

Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A dedicated Locations section lists Arizona (Mayo Clinic, Scottsdale) for the study, replacing the old 'Arizona Locations' label. The HHS Vulnerability Disclosure link has been removed, and the page revision is now v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:32.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updates the page from v3.2.0. There are no substantive changes to study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:56.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the banner about government funding status and potential delays. This notice was a site-wide banner, not part of the core trial information.
    Difference
    0.4%
    Check dated 2025-11-18T07:01:10.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The study details page appears unchanged between the two screenshots. All sections and the overall layout remain the same.
    Difference
    0.5%
    Check dated 2025-11-03T21:04:25.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and new version v3.2.0, replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:37:10.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Incremental version update from v3.0.2 to v3.1.0 with no substantive content changes. If there were conflicting changes, they would be resolved by prioritizing core content and pricing, but here only the revision label updates.
    Difference
    0.1%
    Check dated 2025-09-29T03:08:11.000Z thumbnail image

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.